39 related articles for article (PubMed ID: 9582317)
1. Conservative mutations in the immunosuppressive region of the bovine leukemia virus transmembrane protein affect fusion but not infectivity in vivo.
Gatot JS; Callebaut I; Mornon JP; Portetelle D; Burny A; Kerkhofs P; Kettmann R; Willems L
J Biol Chem; 1998 May; 273(21):12870-80. PubMed ID: 9582317
[TBL] [Abstract][Full Text] [Related]
2. Bovine leukemia virus SU protein interacts with zinc, and mutations within two interacting regions differently affect viral fusion and infectivity in vivo.
Gatot JS; Callebaut I; Van Lint C; Demonté D; Kerkhofs P; Portetelle D; Burny A; Willems L; Kettmann R
J Virol; 2002 Aug; 76(16):7956-67. PubMed ID: 12134000
[TBL] [Abstract][Full Text] [Related]
3. Computational analysis of envelope glycoproteins from diverse geographical isolates of bovine leukemia virus identifies highly conserved peptide motifs.
Pluta A; Albritton LM; Rola-Łuszczak M; Kuźmak J
Retrovirology; 2018 Jan; 15(1):2. PubMed ID: 29310678
[TBL] [Abstract][Full Text] [Related]
4. In vivo rescue of a silent tax-deficient bovine leukemia virus from a tumor-derived ovine B-cell line by recombination with a retrovirally transduced wild-type tax gene.
Van Den Broeke A; Bagnis C; Ciesiolka M; Cleuter Y; Gelderblom H; Kerkhofs P; Griebel P; Mannoni P; Burny A
J Virol; 1999 Feb; 73(2):1054-65. PubMed ID: 9882306
[TBL] [Abstract][Full Text] [Related]
5. The central structural feature of the membrane fusion protein subunit from the Ebola virus glycoprotein is a long triple-stranded coiled coil.
Weissenhorn W; Calder LJ; Wharton SA; Skehel JJ; Wiley DC
Proc Natl Acad Sci U S A; 1998 May; 95(11):6032-6. PubMed ID: 9600912
[TBL] [Abstract][Full Text] [Related]
6. Characterization and application of recombinant Bovine Leukemia Virus Env protein.
Tomé-Poderti L; Olivero-Deibe N; Carrión F; Portela MM; Obal G; Cabrera G; Bianchi S; Lima A; Addiego A; Durán R; Moratorio G; Pritsch O
Sci Rep; 2024 May; 14(1):12190. PubMed ID: 38806566
[TBL] [Abstract][Full Text] [Related]
7. Advances in preventive vaccine development against HTLV-1 infection: A systematic review of the last 35 years.
Santana CS; Andrade FO; da Silva GCS; Nascimento JOS; Campos RF; Giovanetti M; Santos LA; Gois LL; Alcantara LCJ; Barreto FK
Front Immunol; 2023; 14():1073779. PubMed ID: 36860854
[TBL] [Abstract][Full Text] [Related]
8. Mapping of CD4
Bai L; Takeshima SN; Sato M; Davis WC; Wada S; Kohara J; Aida Y
Virol J; 2019 Dec; 16(1):157. PubMed ID: 31842930
[TBL] [Abstract][Full Text] [Related]
9. Three YXXL Sequences of a Bovine Leukemia Virus Transmembrane Protein are Independently Required for Fusion Activity by Controlling Expression on the Cell Membrane.
Matsuura R; Inabe K; Otsuki H; Kurokawa K; Dohmae N; Aida Y
Viruses; 2019 Dec; 11(12):. PubMed ID: 31835517
[TBL] [Abstract][Full Text] [Related]
10. Prostaglandin E
Sajiki Y; Konnai S; Okagawa T; Nishimori A; Maekawa N; Goto S; Watari K; Minato E; Kobayashi A; Kohara J; Yamada S; Kaneko MK; Kato Y; Takahashi H; Terasaki N; Takeda A; Yamamoto K; Toda M; Suzuki Y; Murata S; Ohashi K
J Immunol; 2019 Sep; 203(5):1313-1324. PubMed ID: 31366713
[TBL] [Abstract][Full Text] [Related]
11. Determinants of the Bovine Leukemia Virus Envelope Glycoproteins Involved in Infectivity, Replication and Pathogenesis.
de Brogniez A; Mast J; Willems L
Viruses; 2016 Mar; 8(4):88. PubMed ID: 27023592
[TBL] [Abstract][Full Text] [Related]
12. Recent Advances in BLV Research.
Barez PY; de Brogniez A; Carpentier A; Gazon H; Gillet N; Gutiérrez G; Hamaidia M; Jacques JR; Perike S; Neelature Sriramareddy S; Renotte N; Staumont B; Reichert M; Trono K; Willems L
Viruses; 2015 Nov; 7(11):6080-8. PubMed ID: 26610551
[TBL] [Abstract][Full Text] [Related]
13. Mutation of a Single Envelope N-Linked Glycosylation Site Enhances the Pathogenicity of Bovine Leukemia Virus.
de Brogniez A; Bouzar AB; Jacques JR; Cosse JP; Gillet N; Callebaut I; Reichert M; Willems L
J Virol; 2015 Sep; 89(17):8945-56. PubMed ID: 26085161
[TBL] [Abstract][Full Text] [Related]
14. Even attenuated bovine leukemia virus proviruses can be pathogenic in sheep.
Florins A; Gillet N; Boxus M; Kerkhofs P; Kettmann R; Willems L
J Virol; 2007 Sep; 81(18):10195-200. PubMed ID: 17626096
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of leukemogenesis induced by bovine leukemia virus: prospects for novel anti-retroviral therapies in human.
Gillet N; Florins A; Boxus M; Burteau C; Nigro A; Vandermeers F; Balon H; Bouzar AB; Defoiche J; Burny A; Reichert M; Kettmann R; Willems L
Retrovirology; 2007 Mar; 4():18. PubMed ID: 17362524
[TBL] [Abstract][Full Text] [Related]
16. Molecular characterization of the env gene from Brazilian field isolates of Bovine leukemia virus.
Camargos MF; Pereda A; Stancek D; Rocha MA; dos Reis JK; Greiser-Wilke I; Leite RC
Virus Genes; 2007 Jun; 34(3):343-50. PubMed ID: 16917740
[TBL] [Abstract][Full Text] [Related]
17. Reduced proviral loads during primo-infection of sheep by Bovine Leukemia virus attenuated mutants.
Debacq C; Sanchez Alcaraz MT; Mortreux F; Kerkhofs P; Kettmann R; Willems L
Retrovirology; 2004 Oct; 1():31. PubMed ID: 15462678
[TBL] [Abstract][Full Text] [Related]
18. Dileucine and YXXL motifs in the cytoplasmic tail of the bovine leukemia virus transmembrane envelope protein affect protein expression on the cell surface.
Novakovic S; Sawai ET; Radke K
J Virol; 2004 Aug; 78(15):8301-11. PubMed ID: 15254202
[TBL] [Abstract][Full Text] [Related]
19. Envelope proteins containing single amino acid substitutions support a structural model of the receptor-binding domain of bovine leukemia virus surface protein.
Johnston ER; Albritton LM; Radke K
J Virol; 2002 Nov; 76(21):10861-72. PubMed ID: 12368329
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
